Progressive myoclonic epilepsies: A review of genetic and therapeutic aspects

Lancet Neurology

Volumn 4, Issue 4, 2005, Pages 239-248

  Shahwan, Amre ^a   Farrell, Michael ^a   Delanty, Norman ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; CLONAZEPAM; ETIRACETAM; GUANINE; MITOCHONDRIAL DNA; PHENYTOIN; PIRACETAM; VALPROIC ACID; ZONISAMIDE;

ABSENCE; AMINO ACID SUBSTITUTION; ATAXIA; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; CLINICAL FEATURE; DENTATORUBROPALLIDOLUYSIAN ATROPHY; DISEASE EXACERBATION; DRUG MEGADOSE; DRUG MONITORING; EEG ABNORMALITY; EPILEPTIC DISCHARGE; GENE LOCUS; GENE MUTATION; GENERALIZED EPILEPSY; GENETIC IDENTIFICATION; GENETIC LINKAGE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUNTINGTON CHOREA; MELAS SYNDROME; MERRF SYNDROME; MOLECULAR GENETICS; MYOCLONUS EPILEPSY; NEURONAL CEROID LIPOFUSCINOSIS; PALLIATIVE THERAPY; PHOTOSENSITIVE EPILEPSY; PRIORITY JOURNAL; REVIEW; SEIZURE; SIALIDOSIS;

EID: 15044357259     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(05)70043-0     Document Type: Review

References (108)

1. SF Berkovic Progressive myoclonic epilepsies J Engel TA Pedley Epilepsy: a comprehensive textbook 1997 Lippincott-Raven Philadelphia 2455 2468
2. H Unverricht Die Myoclonie 1891 Franz Deuticke Leipzig
3. H Lundborg Die progressive Myoclonus-Epilepsie (Unverricht's Myoclonie) 1903 Almqvist and Wiksell Uppsala
4. R Norio, M Koskiniemi Progressive myoclonus epilepsy: genetic and nosological aspects with special reference to 107 Finish patients Clin Genet 15 1979 382 398
5. P Genton, R Michelucci, CA Tassinari, J Roger The Ramsay Hunt syndrome revisited: Mediterranean myoclonus versus mitochondrial encephalomyopathy with ragged-red fibers and Baltic myoclonus Acta Neurol Scand 81 1990 8 15
6. M Koskiniemi, M Donner, H Majuri, M Haltia, R Norio Progressive myoclonus epilepsy: a clinical and histopathologic study Acta Neurol Scand 50 1974 307 332
7. AE Lehesjoki Clinical features and genetics of Unverricht-Lundborg disease Adv Neurol 89 2002 193 197
8. M Kyllerman, TK Sommerfelt, A Hedstrom, G Wennergren, D Holmgren Clinical and neurophysiological development of Unverricht-Lundborg disease in four Swedish siblings Epilepsia 32 1991 900 909
9. P Kinirons, N Ibrahim, K Murphy, AE Lehesjoki, I Jarvela, N Delanty Efficacy of levetiracetam in a patient with Unverricht-Lundborg progressive myoclonic epilepsy Neurology 60 2003 1394
10. SF Berkovic, NK So, F Andermann Progressive myoclonus epilepsies: clinical and neurophysiological diagnosis J Clin Neurophysiol 8 1991 261 274
11. 1H MRS study Neurology 58 2002 1686 1689
12. AE Lehesjoki, M Koskiniemi, P Sistonen Localization of a gene for progressive myoclonus epilepsy to chromosome 21q22 Proc Natl Acad Sci U S A 88 1991 3696 3699
13. K Virtaneva, J Miao, AL Traskelin Progressive myoclonus epilepsy EPM1 locus maps to a 175 kb interval in distal 21q Am J Hum Genet 58 1996 1247 1253
14. LA Pennacchio, AE Lehesjoki, NE Stone Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1) Science 271 1996 1731 1734
15. RG Lafreniere, DL Rochefort, N Chretien Unstable insertion in the 5′flanking region of the cystatin-B gene is the most common mutation in progressive myoclonus epilepsy type-1, EPM1 Nat Genet 15 1997 298 302
16. MD Lalioti, M Mirotsou, C Buresi Identification of mutations in cystatin B, the gene responsible for the Unverricht-Lundborg type of progressive myoclonus epilepsy (EPM1) Am J Hum Genet 60 1997 342 351
17. AV Delgado-Escueta, S Ganesh, K Yamakawa Advances in the genetics of progressive myoclonus epilepsy Am J Med Genet 106 2001 129 138
18. R Di Giaimo, M Riccio, S Santi, C Galeotti, DC Ambrosetti, M Melli New insights into the molecular basis of progressive myoclonus epilepsy: a multi-protein complex with cystatin B Hum Mol Genet 11 2002 2941 2950
19. M Iivanainen, JJ Himberg Valproate and clonazepam in the treatment of severe progressive myoclonus epilepsy Arch Neurol 39 1982 236 238
20. C Remy, P Genton Effect of high dose of oral piracetam on myoclonus in progressive myoclonus epilepsy (Mediterranean myoclonus) Epilepsia 32 1991 6
21. A Magaudda, P Gelisse, P Genton Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: clinical observations Epilepsia 45 2004 678 681
22. TR Henry, IE Leppik, RJ Gumnit, M Jacobs Progressive myoclonus epilepsy treated with zonisamide Neurology 38 1988 928 931
23. R Eldridge, M Iivanainen, R Stern, T Koerber, BJ Wilder "Baltic" myoclonus epilepsy: hereditary disorder of childhood made worse by phenytoin Lancet ii 1983 838 842
24. B Smith, R Shatz, K Elisevich, IN Bespalova, M Burmeister Effects of vagus nerve stimulation on progressive myoclonus epilepsy of Unverricht-Lundborg type Epilepsia 41 2000 1046 1048
25. SF Berkovic, F Andermann The progressive myoclonus epilepsies TA Pedley BS Meldrum Recent advances in epilepsy 3 1986 Churchill Livingstone Edinburgh 157 187
26. BLSM Busard, WO Renier, FJM Gabreels, HHJ Jaspar, UJG van Haelst, JL Stooff Lafora's disease Arch Neurol 43 1986 296 299
27. JN Acharya, P Satishchandra, SK Shankar Familial progressive myoclonus epilepsy: clinical and electrophysiologic observations Epilepsia 36 1995 429 434
28. K Kobayashi, K Iyoda, Y Ohtsuka, S Ohtahara, M Yamada Longitudinal clinicoelectrophysiologic study of a case of Lafora disease proven by skin biopsy Epilepsia 31 1990 194 201
29. SF Berkovic, J Cochius, E Andermann, F Andermann Progressive myoclonus epilepsies: clinical and genetic aspects Epilepsia 34 suppl 3 1993 S19 S30
30. BA Minassian Progressive myoclonus epilepsy with polyglucosan bodies: Lafora disease Adv Neurol 89 2002 199 210
31. MW Van Heycop Ten Ham Lafora disease, a form of progressive myoclonus epilepsy O Magnus AML de Haas Handbook of clinical neurology: the epilepsies vol 15 1974 North Holland Publishing Company Amsterdam 382 422
32. K Kobayashi, K Iyoda, Y Ohtsuka, S Ohtahara, M Yamada Longitudinal clinicoelectrophysiologic study of a case of Lafora disease proven by skin biopsy Epilepsia 31 1990 194 201
33. J Roger, P Genton, M Bureau, C Dravet Progressive myoclonus epilepsies in childhood and adolescence J Roger M Bureau C Dravet FE Dreifus A Perret P Wolf Epileptic syndromes in infancy, childhood and adolescence 2nd edn. 1992 John Libbey London 381 400
34. C Yen, A Beydoun, I Drury Longitudinal EEG studies in a kindred with Lafora disease Epilepsia 32 1991 895 899
35. S Carpenter, G Karpati Sweat gland duct cells in Lafora disease: diagnosis by skin biopsy Neurology 31 1981 1564 1568
36. BA Minassian, JR Lee, JA Herbrick Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy Nat Genet 20 1998 171 174
37. S Ganesh, KL Agarwala, K Ueda Laforin, defective in progressive myoclonus epilepsy of Lafora type, is a dual specificity phosphatase associated with polyribosomes Hum Mol Genet 9 2000 2251 2261
38. EM Chan, DE Bulman, AD Paterson Genetic mapping of a new Lafora progressive myoclonus epilepsy locus (EPM2B) on 6p22 J Med Genet 40 2003 671 675
39. EM Chan, S Omer, M Ahmed Progressive myoclonus epilepsy with polyglucosans (Lafora disease). Evidence for a third locus Neurology 63 2004 565 567
40. HS Rosing, LC Hopkins, DC Wallace, CM Epstein, K Weidenheim Maternally inherited mitochondrial myopathy and myoclonic epilepsy Ann Neurol 17 1985 228 237
41. SF Berkovic, S Carpenter, A Evans Myoclonus epilepsy and ragged-red fibers (MERRF). 1. A clinical, pathological, biochemical, magnetic resonance spectroscopic and positron emission tomographic study Brain 112 1989 1231 1260
42. PF Chinnery, N Howell, RN Lightowlers, DM Turnbull Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypes Brain 120 1997 1713 1721
43. S DiMauro, M Hirano, P Kaufmann Clinical features and genetics of myoclonic epilepsy with ragged-red fibers Adv Neurol 89 2002 217 229
44. N So, SF Berkovic, F Andermann, R Kuzniecky, D Gendron, LF Quesney Myoclonus epilepsy and ragged-red fibers (MERRF). 2. Electrophysiological studies and comparison with the other progressive myoclonus epilepsies Brain 112 1989 1261 1276
45. M Hirano, S DiMauro Clinical features of mitochondrial myopathies and encephalomyopathies RJM Lane Handbook of muscle disease 1996 Marcel Dekker Inc New York 479 504
46. Lys mutation in skeletal muscle of patients with myoclonic epilepsy and ragged-red fibers (MERRF) Am J Hum Genet 51 1992 1187 1200
47. AJ Barkovich, WV Good, TK Koch, BO Berg Mitochondrial disorders: analysis of their clinical and imaging characteristics Am J Neuroradiol 14 1993 1119 1137
48. Lys mutation Cell 61 1990 931 937
49. Lys gene associated with myoclonic epilepsy and ragged-red fibers (MERRF) Am J Hum Genet 51 1992 1213 1217
50. Lys gene (G8363A) Am J Hum Genet 58 1996 933 939
51. SR Hammans, MG Sweeney, M Brockington, JA Morgan-Hughes, AE Harding Mitochondrial encephalopathies: molecular genetic diagnosis from blood samples Lancet 337 1991 1311 1313
52. S DiMauro, M Hirano, EA Schon Mitochondrial encephalomyopathies: therapeutic approaches Neurol Sci 21 suppl 5 2000 S901 S908
53. I Tein, S DiMauro, Z-W Xie, DC De Vivo Valproic acid impairs carnitine uptake in cultured human skin fibroblasts: an in vitro model for pathogenesis of valproic acid-associated carnitine deficiency Pediatr Res 34 1993 281 287
54. RW Taylor, PF Chinnery, DM Turnbull, RN Lightowlers Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids Nat Genet 51 1997 212 215
55. T Taivassalo, K Fu, T Johns, D Arnold, G Karpati, EA Shoubridge Gene shifting: a novel therapy for mitochondrial myopathy Hum Mol Genet 8 1999 1047 1052
56. RM Andrews, PG Griffiths, PF Chinnery, DM Turnbull Evaluation of bupivacaine-induced muscle regeneration in the treatment of ptosis in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome Eye 13 1999 769 772
57. DH Boehme, JC Cottrell, SC Leonberg, W Zeman A dominant form of neuronal ceroid-lipofuscinosis Brain 94 1971 745 760
58. RM Gardiner Clinical features and molecular genetics basis of the neuronal ceroid lipofuscinoses Adv Neurol 89 2002 211 215
59. JD Sharp, RB Wheeler, BD Lake Loci for classical and a variant late infantile neuronal ceroid lipofuscinosis map to chromosomes 11p15 and 15q21-23 Hum Mol Genet 6 1997 591 595
60. DE Sleat, RM Gin, I Sohar Mutation analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorder Am J Hum Genet 64 1999 1511 1523
61. P Santavuori, J Rapola, K Sainio, C Raitta A variant of Jansky-Bielschowsky disease Neuropediatrics 13 1982 135 141
62. M Savukoski, M Kestila, R Williams Defined chromosomal assignment of CLN5 demonstrates that at least four genetic loci are involved in the pathogenesis of human ceroid lipofuscinoses Am J Hum Genet 55 1994 695 701
63. JD Sharp, RB Wheeler, KA Parker, RM Gardiner, RE Williams, SE Mol Spectrum of CLN6 mutations in variant late infantile neuronal ceroid lipofuscinosis Hum Mutat 22 2003 35 42
64. I Rapin Myoclonus in neuronal storage and Lafora diseases Adv Neurol 43 1986 65 85
65. BF Westmoreland, RV Groover, FW Sharbrough Electrographic findings in three types of cerebromacular degeneration Mayo Clin Proc 54 1979 12 21
66. H Eiberg, RM Gardiner, J Mohr Batten disease (Spielmeyer-Sjogren disease) and haptoglobins (HP): indication of linkage and assignment to chromosome 16 Clin Genet 36 1989 217 218
67. IE Jarvela, HM Mitchison, DF Callen Physical map of the region containing the gene for Batten disease (CLN3) Am J Med Genet 57 1995 316 319
68. RE Haskell, CJ Carr, DA Pearce, MJ Bennett, BL Davidson Batten disease: evaluation of CLN3 mutations on protein localization and function Hum Mol Genet 9 2000 735 744
69. SF Berkovic, S Carpenter, F Andermann Kuf's disease: a critical reappraisal Brain 111 1988 27 62
70. MA Barthez-Carpentier, C Billard, J Maheut, JJ Santini, MM Ruchoux A case of childhood Kuf's disease J Neurol Neurosurg Psychiatry 54 1991 655 657
71. L D'Incerti MRI in neuronal ceroid lipofuscinosis Neurol Sci 21 suppl 3 2000 571 573
72. KE Wisniewski, N Zhong, M Philippart Pheno/genotypic correlations of neuronal ceroid lipofuscinoses Neurology 57 2001 576 581
73. J Rapola, P Santavuori, E Savilahti Suction biopsy of rectal mucosa in the diagnosis of infantile and juvenile types of neuronal ceroid lipofuscinoses Hum Pathol 15 1984 352 360
74. S Carpenter Morphological diagnosis and misdiagnosis in Batten-Kufs disease Am J Med Genet Suppl 5 1988 85 91
75. S Carpenter, G Karpati, F Andermann, JC Jacob, E Andermann The ultrastructural characteristics of the abnormal cytosomes in Batten-Kufs disease Brain 100 1977 137 156
76. C Callagy, G O'Neill, SF Murphy, MA Farrell Adult neuronal ceroid lipofuscinosis (Kufs' disease) in two siblings of an Irish family Clin Neuropathol 19 2000 109 118
77. P Santavuori, T Westermark, J Rapola Antioxidant treatment in Spielmeyer-Sjogren's disease Acta Neurol Scand 71 1985 136 145
78. D Sondhi, NR Hackett, RL Apblett, SM Kaminsky, RG Pergolizzi, RG Crystal Feasibility of gene therapy for late neuronal ceroid lipofuscinosis Arch Neurol 58 2001 1793 1798
79. EF Neufeld, JC Fratantoni Inborn errors of mucopolysaccharide metabolism Science 169 1970 141 146
80. RM Taylor, JH Wolfe Cross correction of β-glucoronidase deficiency by retroviral vector-mediated gene transfer Exp Cell Res 214 1995 606 613
81. RE Haskell, SM Hughes, JA Chiorini, JM Alisky, BL Davidson Viral-mediated delivery of the late-infantile neuronal ceroid lipofuscinosis gene, TPP-I to the mouse central nervous system Gene Ther 10 2003 34 42
82. I Rapin, S Goldfisher, R Katzman, J Engel Jr, JS O'Brien The cherry-red spot myoclonus syndrome Ann Neurol 3 1978 234 242
83. J Engel Jr, I Rapin, D Giblin Electrophysiological studies in two patients with cherry-red spot myoclonus syndrome Epilepsia 18 1977 73 87
84. S Palmeri, M Villanova, A Malandrini Type I sialidoses: a clinical, biochemical and neuroradiological study Eur Neurol 43 2000 88 94
85. AV Pshezhetsky, C Richard, L Michaud Cloning, expression and chromosomal mapping of lysosomal sialidase and characterization of mutations in sialidosis Nat Genet 15 1997 316 320
86. KE Lukong, K Landry, MA Elsliger Mutations in sialidoses impair sialidase binding to the lysosomal multienzyme complex J Biol Chem 276 2001 17286 17290
87. S Pattison, M Pankarican, CA Rupar, FL Graham, SA Igdoura Five novel mutations in the lysosomal sialidase gene (NEU1) in type II sialidosis patients and assessment of their impact on enzyme activity and intracellular target using adenovirus-mediated expression Hum Mutat 23 2004 32 39
88. V Seyrantepe, H Poupetova, R Froissart, MT Zabot, I Maire, AV Pshezhetsky Molecular pathology of NEU1 gene in sialidosis Hum Mutat 22 2003 343 352
89. CB Rothschild, G Akots, R Hayworth A genetic map of chromosome 20q12-q13.2 Am J Hum Genet 52 1993 110 123
90. NJ Galjart, N Gillemans, A Harris Expression of cDNA encoding the human "protective protein" associated with lysosomal beta-galactosidase and neuraminidase: homology to yeast proteases Cell 54 1988 755 764
91. T Leimig, L Mann, MdP Martin Functional amelioration of murine galactosialidosis by genetically modified bone marrow hematopoietic progenitor cells Blood 99 2002 3169 3178
92. JA Lowden, JS O'Brien Sialidosis: a review of human neuraminidase deficiency Am J Hum Genet 31 1979 1 18
93. TT Warner, L Williams, A Harding DRPLA in Europe Nat Genet 6 1994 225
94. NT Potter, MA Meyer, AW Zimmerman, ML Eisentadt, IJ Anderson Molecular and clinical findings in a family with dentatorubral-pallidoluysian atrophy Ann Neurol 37 1995 273 277
95. M Connatry, NR Dennis, C Patch, JN Macpherson, JF Harvey Molecular reinvestigation of patients with Huntington's disease in Wessex reveals a family with dentatorubral and pallidoluysian atrophy Hum Genet 97 1996 76 78
96. H Natio, S Oyanagi Familial myoclonus epilepsy and choreoathetosis: hereditary dentatorubral-pallidoluysian atrophy Neurology 32 1982 798 807
97. R Iizuka, K Hirayama, K Maehara Dentato-rubro-pallido-luysian atrophy: a clinico-pathological study J Neurol Neurosurg Psychiatry 47 1984 1288 1298
98. R Koide, T Ikeuchi, O Onodera Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA) Nat Genet 6 1994 9 13
99. S Nagafuchi, H Yanagisawa, K Sato Expansion of an unstable CAG trinucleotide on chromosome 12p in dentatorubral and pallidoluysian atrophy Nat Genet 6 1994 14 18
100. S Tsuji Dentatorubral-pallidoluysian atrophy: clinical aspects and molecular genetics Adv Neurol 89 2002 231 239
101. F Andermann, E Andermann, S Carpenter Action myoclonus-renal failure syndrome Adv Neurol 43 1986 87 103
102. A Gambardella, M Muglia, A Labate Juvenile Huntington's disease presenting as progressive myoclonic epilepsy Neurology 57 2001 708 711
103. RL Daucher, PD Holohan, AE Shrimpton Familial encephalopathy with neuroserpin inclusion bodies Am J Pathol 155 1999 1901 1913
104. SF Berkovic, J Cochius, E Andermann, F Andermann Progressive myoclonus epilepsies: clinical and genetic aspects Epilepsia 34 suppl 3 1993 S19 S30
105. JA Conry Progressive myoclonic epilepsies J Child Neurol 17 suppl 1 2002 S80 S84
106. SD Shorvon General principles of treatment in epilepsy Handbook of epilepsy treatment 2000 Blackwell Science Oxford 71
107. J Janszky, G Rasonyi, P Halasz Disabling erratic myoclonus during lamotrigine therapy with high serum level, report of two cases Clin Neuropharmacol 23 2000 86 89
108. KB Das, C Harris, DP Smyth, JH Cross Unusual side effects of lamotrigine therapy J Child Neurol 18 2003 479 480